The University of Auckland is a public research university based in Auckland, New Zealand. It is the largest, most comprehensive and highest-ranked university in New Zealand and consistently places among the Top 100 universities in the world.

During the past decade, University of Auckland conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 4 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 4 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Auckland" #1 sponsor was "University of Auckland, New Zealand" with 13 trials, followed by "Alere San Diego" with 2 trials sponsored, "Amicus Therapeutics" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored and "Allergan" with 1 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Auckland" #1 collaborator was "AgResearch" with 2 trials as a collaborator, "Auckland Medical Research Foundation" with 2 trials as a collaborator, "Health Research Council, New Zealand" with 2 trials as a collaborator, "Singapore Institute for Clinical Sciences" with 2 trials as a collaborator and "University of Auckland, New Zealand" with 2 trials as a collaborator. Other collaborators include 45 different institutions and companies that were collaborators in the rest 54 trials.

According to Clinical.Site data, the most researched conditions in "University of Auckland" are "Heart Failure" (6 trials), "Acute Pancreatitis" (2 trials), "Obesity" (2 trials), "Pompe Disease (Late-onset)" (2 trials) and "Acute Decompensated Heart Failure" (1 trials). Many other conditions were trialed in "University of Auckland" in a lesser frequency.

Most popular intervention types in "University of Auckland" are "Drug" (15 trials), "Other" (9 trials), "Device" (4 trials), "Procedure" (4 trials) and "Behavioral" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "AT2221" (2 trials), "ATB200" (2 trials), "0.9% Saline" (1 trials) and "480 Mometasone Furoate Sinus Drug Depot" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Auckland" are 31 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University of Auckland". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 18 completed trials in University of Auckland, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of Auckland, 3 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 14 trials that are defined as “Not Applicable".

University of Auckland has several departments that took part in Clinical trials: "University of Auckland School of Medicine" - 2 trials, "CBR Neurogenetic Research Clinic, University of Auckland" - 2 trials, "NeuroActiva-Clinical Research Unit" - 2 trials